• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Education for patients with rheumatic diseases being treated with biologics: need, strategies, challenges, and solutions.

作者信息

Santhanam Sham, Ravindran Vinod

机构信息

Department of Rheumatology, Kauvery Hospital, Alwarpet, Chennai, Tamil Nadu, India.

Centre for Rheumatology, Calicut, Kerala, India.

出版信息

Clin Rheumatol. 2025 Feb;44(2):533-535. doi: 10.1007/s10067-025-07315-0. Epub 2025 Jan 14.

DOI:10.1007/s10067-025-07315-0
PMID:39808232
Abstract
摘要

相似文献

1
Education for patients with rheumatic diseases being treated with biologics: need, strategies, challenges, and solutions.接受生物制剂治疗的风湿病患者的教育：需求、策略、挑战及解决方案。
Clin Rheumatol. 2025 Feb;44(2):533-535. doi: 10.1007/s10067-025-07315-0. Epub 2025 Jan 14.
2
Comparison of group versus individual patient education for promoting safety skills of patients with autoimmune rheumatic diseases treated with biologics: a multicentre randomised controlled trial.团体教育与个体患者教育对促进接受生物制剂治疗的自身免疫性风湿病患者安全技能的比较：一项多中心随机对照试验。
Clin Rheumatol. 2025 Jan;44(1):487-494. doi: 10.1007/s10067-024-07218-6. Epub 2024 Nov 5.
3
[Biologics and mycobacterial diseases].[生物制剂与分枝杆菌病]
Kekkaku. 2013 Mar;88(3):337-53.
4
Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice.风湿性疾病患者使用传统的疾病修饰抗风湿药物和非抗肿瘤坏死因子生物制剂与结核再激活风险及临床建议。
Expert Opin Drug Saf. 2019 May;18(5):415-425. doi: 10.1080/14740338.2019.1612872. Epub 2019 May 8.
5
High incidence of tuberculosis infection in rheumatic diseases and impact for chemoprophylactic prevention of tuberculosis activation during biologics therapy.风湿性疾病中结核病感染的高发生率以及生物制剂治疗期间化学预防结核病激活的影响。
Clin Vaccine Immunol. 2013 Jun;20(6):842-7. doi: 10.1128/CVI.00049-13. Epub 2013 Apr 3.
6
Biotherapies in Medical Practice: A Review and the Nigerian Experience.医学实践中的生物疗法：综述及尼日利亚经验。
West Afr J Med. 2021 May 29;38(5):486-493.
7
Why Do Patients with Chronic Inflammatory Rheumatic Diseases Discontinue Their Biologics? An Assessment of Patients' Adherence Using a Self-report Questionnaire.慢性炎性风湿性疾病患者为何停用生物制剂？使用自我报告问卷评估患者的依从性。
J Rheumatol. 2016 Apr;43(4):724-30. doi: 10.3899/jrheum.150414. Epub 2016 Feb 15.
8
Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road.患有风湿性疾病的女性在孕期和哺乳期使用生物制剂：前行中的安全性临床证据。
Front Pharmacol. 2021 Feb 11;12:621247. doi: 10.3389/fphar.2021.621247. eCollection 2021.
9
Vaccines and biologics.疫苗和生物制品。
Ann Rheum Dis. 2014 Aug;73(8):1446-54. doi: 10.1136/annrheumdis-2014-205246. Epub 2014 May 20.
10
Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India.生物制剂与自身免疫性风湿疾病中的结核病风险：来自印度的真实世界临床经验
Int J Rheum Dis. 2019 Feb;22(2):280-287. doi: 10.1111/1756-185X.13376. Epub 2018 Aug 30.

本文引用的文献

1
Comparison of group versus individual patient education for promoting safety skills of patients with autoimmune rheumatic diseases treated with biologics: a multicentre randomised controlled trial.团体教育与个体患者教育对促进接受生物制剂治疗的自身免疫性风湿病患者安全技能的比较：一项多中心随机对照试验。
Clin Rheumatol. 2025 Jan;44(1):487-494. doi: 10.1007/s10067-024-07218-6. Epub 2024 Nov 5.
2
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.EULAR 推荐的类风湿关节炎治疗方案：使用合成和生物疾病修正抗风湿药物：2022 更新版。
Ann Rheum Dis. 2023 Jan;82(1):3-18. doi: 10.1136/ard-2022-223356. Epub 2022 Nov 10.
3
Assessing acceptability and identifying barriers and facilitators to implementation of the EULAR recommendations for patient education in inflammatory arthritis: a mixed-methods study with rheumatology professionals in 23 European and Asian countries.
评估欧洲抗风湿病联盟（EULAR）关于炎性关节炎患者教育建议的可接受性，并确定实施过程中的障碍和促进因素：一项对23个欧洲和亚洲国家的风湿病专业人员开展的混合方法研究。
Ann Rheum Dis. 2022 Oct;81(10):1348-1357. doi: 10.1136/annrheumdis-2022-222253. Epub 2022 Jun 8.
4
Efficacy of a nurse-led patient education intervention in promoting safety skills of patients with inflammatory arthritis treated with biologics: a multicentre randomised clinical trial.护士主导的患者教育干预在促进生物制剂治疗的炎症性关节炎患者安全技能中的效果：一项多中心随机临床试验。
RMD Open. 2022 Mar;8(1). doi: 10.1136/rmdopen-2021-001828.
5
Adherence to Subcutaneous Anti-TNF Treatment in Chronic Inflammatory Rheumatism and Therapeutic Patient Education.慢性炎症性风湿病皮下抗TNF治疗的依从性及治疗患者教育
Patient Prefer Adherence. 2020 Feb 24;14:363-369. doi: 10.2147/PPA.S240179. eCollection 2020.
6
EULAR recommendations for patient education for people with inflammatory arthritis.EULAR 推荐炎症性关节炎患者的教育建议。
Ann Rheum Dis. 2015 Jun;74(6):954-62. doi: 10.1136/annrheumdis-2014-206807. Epub 2015 Mar 3.
7
The effect of rheumatoid arthritis disease education on adherence to medications and followup in Kerala, India.类风湿性关节炎疾病教育对印度喀拉拉邦药物依从性及随访的影响。
J Rheumatol. 2013 Aug;40(8):1460-1. doi: 10.3899/jrheum.130350.
8
The effect of an educational programme consisting of group and individual arthritis education for patients with polyarthritis--a randomised controlled trial.一项由团体和个体关节炎教育组成的教育计划对多发性关节炎患者的影响 - 一项随机对照试验。
Patient Educ Couns. 2012 Jul;88(1):113-20. doi: 10.1016/j.pec.2011.12.011. Epub 2012 Jan 23.